Prevalence and risk factors for reflux esophagitis in patients with chronic obstructive pulmonary disease

Korean Journal of Internal Medicine

Volumn 29, Issue 4, 2014, Pages 466-473

  Kim, Seo Woo ^a   Lee, Jin Hwa ^a   Sim, Yun Su ^b   Ryu, Yon Ju ^a   Chang, Jung Hyun ^a  

^a Ewha Womans University School of Medicine   (South Korea)

^b Hallym University   (South Korea)

Author keywords

Chronic obstructive; Esophagitis; Peptic; Prevalence; Pulmonary disease; Risk factors

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGE; AGED; ARTICLE; BRONCHOSPIROGRAPHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; REFLUX ESOPHAGITIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; COMORBIDITY; ESOPHAGITIS, PEPTIC; FACTUAL DATABASE; GASTROINTESTINAL ENDOSCOPY; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTECTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK; SOUTH KOREA; SPIROMETRY; STATISTICAL MODEL;

ADMINISTRATION, INHALATION; AGED; CHI-SQUARE DISTRIBUTION; CHOLINERGIC ANTAGONISTS; COMORBIDITY; DATABASES, FACTUAL; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGITIS, PEPTIC; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; PROTECTIVE FACTORS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SPIROMETRY;

EID: 84904545247     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2014.29.4.466     Document Type: Article

References (30)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Diagnosis, Management, and Prevention of COPD [Internet]. London (UK): Global Initiative for Chronic Obstructive Lung Disease, 2014 [cited 2013 May 7]. Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html.
2. Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005;60:925-931.
3. Molassiotis A, Bryan G, Caress A, Bailey C, Smith J. Pharmacological and non-pharmacological interventions for cough in adults with respiratory and non-respiratory diseases: a systematic review of the literature. Respir Med 2010;104:934-944.
4. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-1138.
5. Garcia Rodriguez LA, Ruigomez A, Martin-Merino E, Johansson S, Wallander MA. Relationship between gastroesophageal reflux disease and COPD in UK primary care. Chest 2008;134:1223-1230.
6. Mokhlesi B, Morris AL, Huang CF, Curcio AJ, Barrett TA, Kamp DW. Increased prevalence of gastroesophageal reflux symptoms in patients with COPD. Chest 2001;119:1043-1048.
7. Casanova C, Baudet JS, del Valle Velasco M, et al. Increased gastro-oesophageal reflux disease in patients with severe COPD. Eur Respir J 2004;23:841-845.
8. Terada K, Muro S, Sato S, et al. Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation. Thorax 2008;63:951-955.
9. Rascon-Aguilar IE, Pamer M, Wludyka P, et al. Role of gastroesophageal reflux symptoms in exacerbations of COPD. Chest 2006;130:1096-1101.
10. Rogha M, Behravesh B, Pourmoghaddas Z. Association of gastroesophageal reflux disease symptoms with exacerbations of chronic obstructive pulmonary disease. J Gastrointestin Liver Dis 2010;19:253-256.
11. Takada K, Matsumoto S, Kojima E, et al. Prospective evaluation of the relationship between acute exacerbations of COPD and gastroesophageal reflux disease diagnosed by questionnaire. Respir Med 2011;105:1531-1536.
12. Oue K, Mukaisho K, Higo T, et al. Histological examination of the relationship between respiratory disorders and repetitive microaspiration using a rat gastro-duodenal contents reflux model. Exp Anim 2011;60:141-150.
13. Chen TS, Chang FY. The prevalence and risk factors of reflux esophagitis among adult Chinese population in Taiwan. J Clin Gastroenterol 2007;41:819-822.
14. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-1920.
15. Kempainen RR, Savik K, Whelan TP, Dunitz JM, Herrington CS, Billings JL. High prevalence of proximal and distal gastroesophageal reflux disease in advanced COPD. Chest 2007;131:1666-1671.
16. Cho YK, Kim GH, Kim JH, et al. Diagnosis of gastroesophageal reflux disease: a systematic review. Korean J Gastroenterol 2010;55:279-295.
17. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710-717.
18. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136.
19. Lee SJ, Song CW, Jeen YT, et al. Prevalence of endoscopic reflux esophagitis among Koreans. J Gastroenterol Hepatol 2001;16:373-376.
20. Lee HL, Eun CS, Lee OY, et al. Association between GERD-related erosive esophagitis and obesity. J Clin Gastroenterol 2008;42:672-675.
21. Shim KN, Hong SJ, Sung JK, et al. Clinical spectrum of reflux esophagitis among 25,536 Koreans who underwent a health check-up: a nationwide multicenter prospective, endoscopy-based study. J Clin Gastroenterol 2009;43:632-638.
22. Noh YW, Jung HK, Kim SE, Jung SA. Overlap of erosive and non-erosive reflux diseases with functional gastrointestinal disorders according to Rome III criteria. J Neurogastroenterol Motil 2010;16:148-156.
23. Jung HK. Epidemiology of gastroesophageal reflux disease in Asia: a systematic review. J Neurogastroenterol Motil 2011;17:14-27.
24. Du J, Liu J, Zhang H, Yu CH, Li YM. Risk factors for gastroesophageal reflux disease, reflux esophagitis and non-erosive reflux disease among Chinese patients undergoing upper gastrointestinal endoscopic examination. World J Gastroenterol 2007;13:6009-6015.
25. El-Serag H, Hill C, Jones R. Systematic review: the epidemiology of gastro-oesophageal reflux disease in primary care, using the UK General Practice Research Database. Aliment Pharmacol Ther 2009;29:470-480.
26. Ruigomez A, Garcia Rodriguez LA, Wallander MA, Johansson S, Graffner H, Dent J. Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther 2004;20:751-760.
27. Cui Y, Devillier P, Kuang X, et al. Tiotropium reduction of lung inflammation in a model of chronic gastro-oesophageal reflux. Eur Respir J 2010;35:1370-1376.
28. Braman SS. Chronic cough due to chronic bronchitis: ACCP evidence-based clinical practice guidelines. Chest 2006;129(1 Suppl):104S-115S.
29. Lowry R, Wood A, Higenbottam T. The effect of anticholinergic bronchodilator therapy on cough during upper respiratory tract infections. Br J Clin Pharmacol 1994;37:187-191.
30. Dicpinigaitis PV, Spinner L, Santhyadka G, Negassa A. Effect of tiotropium on cough reflex sensitivity in acute viral cough. Lung 2008;186:369-374.